ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Minnesota Health Market Review 2025 | Medicaid Enrollment Sees Sharp Decline; HMOs Report $1 Billion Revenue Drop - ResearchAndMarkets.com

The "Minnesota Health Market Review 2025 (Part 1)" report has been added to ResearchAndMarkets.com's offering.

HMO profitability plunged in 2024, as HMOs and County-Based Purchasing plans reported lower revenues, higher medical expenses and large losses on operations. The number of enrollees in Medicaid managed care plans dropped by about 207,000 in 2023 and 2024, although it is still higher than before the COVID-19 pandemic.

The analyst reports on these and other findings in Part One of Minnesota Health Market Review 2025. This is the 36th edition of the report, which was first published in 1990. The reports in Minnesota and five other states examine key trends and competitive strategies for health plan companies and hospital systems in those markets. Later this year, the Part Two report for Minnesota will present an analysis of the state's hospital systems and how they compete, examining 2024 Medicare cost report data on their financial results and measures of inpatient utilization.

The new report finds that:

  • Total enrollment in HMOs and County-Based Purchasing (CBP) plans dropped by 168,000 or 9.7% in 2024. While membership in Medicare Advantage plans grew by 8.7%, enrollment in Medicaid and other state programs decreased by 15%, as the state completed re-evaluating the eligibility of Medicaid recipients.
  • As enrollment dropped, premium revenues for HMOs dropped by more than $1 billion, or 6.5%. However, their medical costs increased, and they had combined underwriting losses of $1.067 billion. UCare had the largest underwriting losses at $606.5 million, followed by HealthPartners ($170.9 million) and Medica Health Plans ($154.3 million). Hennepin Health had underwriting losses of $56.2 million.
  • Most of the losses were in two key lines of business: Medicaid and other public programs and Medicare Advantage. HMOs and county plans lost $640.4 million on Medicaid plans in 2024 after reporting underwriting profits of $367.8 million in 2023 and $726.5 million in 2022, their best results ever. Even with the large losses in 2024, Medicaid plans have posted underwriting income of $939.5 million in the last 10 years. That includes the results for Minnesota Senior Health Options, a managed care program for beneficiaries of both Medicare and Medicaid, where the health plans have reported combined underwriting income of $720.3 million in the last nine years.
  • Enrollment in Medicare Advantage plans has grown steadily since 2016, but they have not been profitable in Minnesota since 2022. In 2024, UCare lost $266.7 million on its Medicare Advantage plans, including $102.3 million in reserves set aside in anticipation of future revenue shortfalls. It already spent $47 million from that reserve in the first quarter of 2025 but still lost $25.5 million. Other health plans reported improved results in the first three months of 2025.
  • Data from 2023 show that 96% of Minnesotans have health insurance, but that is likely to drop sharply if the budget bill passed by the U.S. House of Representatives is enacted. Cuts to Medicaid are projected to result in about 253,000 Minnesotans losing Medicaid benefits. Changes to subsidies sold on the MNsure exchange, where individual enrollment has grown to 167,000, will likely result in thousands losing coverage.

Key Topics Covered:

  • Introduction
  • Market Structure
  • Health Plan Companies
  • Network Arrangements and Provider Systems
  • Trend Analysis
  • Health Plan Enrollment
  • Individual Markets and MNsure
  • State Health Care Programs
  • Medicare Health Plans
  • Health Plan Profitability
  • Financial Results by Line of Business
  • Health Plan Capital
  • A Look Ahead

For more information about this report visit https://www.researchandmarkets.com/r/ripuro

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com



For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.